*Important Note: Obtaining prescription weight loss products requires an online consultation with a licensed healthcare provider who will determine if the treatment is medically appropriate for you. Not all treatments may be available. Please refer to the vital safety information below. Any benefits mentioned are based on third-party sources, where applicable. Medications may be offered as a subscription service, which you can cancel anytime. Please review our policies for further details. Actual product packaging may differ from the images shown. Individual results may vary.

AIM | Weight Loss will facilitate a consultation with a qualified healthcare provider if you seek a prescription. This professional will assess your suitability for the prescription item. If deemed suitable, a doctor may issue a prescription for the item, which can be filled at a partner pharmacy unless you specify an alternative preference.

Zepbound™ and Wegovy® are FDA-approved specifically for weight loss. Ozempic®, Ryselbus®, and Mounjaro® are FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider’s discretion.

**As an alternative to these FDA-approved branded products, a provider may prescribe a compounded drug that can be effective when prescribed off-label for weight loss. State-licensed sterile compounding pharmacies prepare stack-sourced compounded drugs; however, compounded GLP-1 medications are not FDA-approved.

The FDA-approved brand name drugs, such as Saxenda®, Victoza®, Wegovy®, and Ozempic®, are exclusively made by the Novo Nordisk™ company. Eli Lilly and Company™ exclusively make Mounjaro™ and Zepbound™. Stack does not claim any affiliation with, or endorsement from, the products mentioned above or entities.

Note: The Food and Drug Administration has not evaluated the above statements. This product is not intended to diagnose, treat, cure, or prevent any disease.